PepsiCo And Monster: Diving Into Human Behavior

Sofiia TiulenevaInvestment Thesis In this article, I explore how GLP-1 weight-loss drugs, from Eli Lilly (LLY) and Novo Nordisk (NVO), have impacted people and external industries. While partly discussing the significance of these drugs in the obesity management field, the predominant aspect of the article will emphasize their influence on the beverage market. For instance, I believe PepsiCo (PEP) will sustain its market sales in the snack division due to consumer habits, even though there was an initia ...